Phathom Pharmaceuticals, Inc. (58) | Human Resources (22)
Browse by Subcategory
Recent Contracts
-
Transition and Separation Agreement and Release of Claims, dated April 5, 2022, by and between the Registrant and Anthony Guzzo
(Filed With SEC on August 2, 2022)
-
Amended and Restated Non-Employee Director Compensation Policy
(Filed With SEC on August 2, 2022)
-
Form of Restricted Stock Grant Notice and Restricted Stock Agreement under Phathom Pharmaceuticals, Inc. 2019 Equity Incentive Plan
(Filed With SEC on August 2, 2022)
-
Employment Letter Agreement, dated March 22, 2022, by and between Molly Henderson and the Company
(Filed With SEC on May 10, 2022)
-
Form of Restricted Stock Unit Agreement under the 2019 Incentive Award Plan
(Filed With SEC on January 25, 2022)
-
Amended and Restated Non-Employee Director Compensation Policy
(Filed With SEC on August 10, 2021)
-
Separation and Release Agreement dated June 4, 2021, between the Registrant and Todd Branning
(Filed With SEC on August 10, 2021)
-
Form of Performance Share Unit Grant Notice and Performance Share Unit Agreement under Phathom Pharmaceuticals, Inc. 2019 Incentive Award Plan
(Filed With SEC on August 6, 2020)
-
Form of Stock Option Grant Notice and Stock Option Agreement under the Phathom Pharmaceuticals, Inc. 2019 Incentive Award Plan
(Filed With SEC on August 6, 2020)
-
Employment Letter Agreement, dated June 25, 2020, by and between Todd Branning and the Company
(Filed With SEC on July 13, 2020)
-
Phathom Pharmaceuticals 2020 Bonus Plan
(Filed With SEC on May 12, 2020)
-
Phathom Pharmaceuticals, Inc. 2019 Incentive Award Plan and form of stock option grant notice and stock option agreement thereunder
(Filed With SEC on October 15, 2019)
-
Non-Employee Director Compensation Program
(Filed With SEC on October 15, 2019)
-
Phathom Pharmaceuticals, Inc. 2019 Equity Incentive Plan
(Filed With SEC on September 30, 2019)
-
Form of Stock Option Grant Notice and Stock Option Agreement under Phathom Pharmaceuticals, Inc. 2019 Equity Incentive Plan
(Filed With SEC on September 30, 2019)
-
Form of Restricted Stock Grant Notice and Restricted Stock Agreement under Phathom Pharmaceuticals, Inc. 2019 Equity Incentive Plan
(Filed With SEC on September 30, 2019)
-
Phathom Pharmaceuticals, Inc. 2019 Incentive Award Plan and form of stock option grant notice and stock option agreement thereunder
(Filed With SEC on September 30, 2019)
-
Non-Employee Director Compensation Program
(Filed With SEC on September 30, 2019)
-
Employment Letter Agreement, dated July 21, 2019, by and between David Socks and the Registrant
(Filed With SEC on September 30, 2019)
-
Amended and Restated Employment Letter Agreement, dated September 25, 2019, by and between Azmi Nabulsi, M.D., M.P.H. and the Registrant
(Filed With SEC on September 30, 2019)
-
Employment Letter Agreement, dated July 23, 2019, by and between Aditya Kohli, Ph.D. and the Registrant
(Filed With SEC on September 30, 2019)
-
Employment Letter Agreement, dated August 29, 2019, by and between Terrie Curran and the Registrant
(Filed With SEC on September 30, 2019)